Boehringer Ingelheim is incubating the most creative ideas and pioneering emerging fields of research to accelerate the delivery of next-generation medicines to the patients we serve. The promotion of science and basic research is part if this strong committment to early innovation.The Boehringer Ingelheim Foundation, the Boehringer Ingelheim Fonds, the IMP and the IMB are examples of this committment.
Fostering young researchers worldwide
In 1983, the Boehringer Ingelheim Fonds was established as a public foundation. An independent, non-profit institution, its purpose is the exclusive and direct promotion of basic research in biomedicine. The Boehringer Ingelheim Fonds supports the most talented young researchers worldwide whose PhD or MD projects are aimed at experimentally elucidating basic phenomena of human life.
Only the best applicants are accepted after an extremely rigorous application process.
Twice a year, the Boehringer Ingelheim Fonds invites scientists of worldwide repute to its International Titisee Conferences. Since 1962, experts from all nations have been meeting in the Black Forest (southern Germany) to discuss the latest results and developments in different areas of the molecular life sciences. Click hereto read more about Boehringer Ingelheim Fonds
Together with other leading pharmaceutical companies Boehringer Ingelheim Animal Health engages in Vac2Vac, a joint EU research project which aims at improving animal welfare in vaccine quality control.
Boehringer Ingelheim BioXcellence™ provides the entire drug product manufacturing chain comprising filling, lyophilisation and visual inspection. Within our global manufacturing network, we can supply different dosage forms.
The process development of biopharmaceuticals requires specific expertise in both up- and downstream, as well as in protein analytics. By outsourcing the process development of your biotechnology projects to Boehringer Ingelheim BioXcellence™, you gain access not only to a team of highly skilled and experienced staff, but also to the most innovative technologies.
The Boehringer Ingelheim Foundation as well as the Boehringer Ingelheim Fonds are non-profit organisations, which act independently of the company. Both foundations are dedicated to the exclusive and direct promotion of science and basic research.